Sana Health

Sana Health is a clinical-stage digital therapeutics company built on a founder's personal quest to overcome debilitating chronic pain. Its core technology is a wearable audiovisual device designed to modulate neural pathways to provide relief from conditions such as neuropathic pain and PTSD. The company has achieved significant regulatory milestones, including FDA Breakthrough Device Designation and submission of pivotal De Novo data for neuropathic pain, positioning it for potential market entry in a major indication. Backed by defense funding and a veteran team, Sana is advancing a pipeline focused on large, underserved neurological and psychiatric conditions.

Wearable, closed-loop audiovisual neuromodulation device that uses biometric feedback to personalize stimulation patterns aimed at entraining brainwaves and promoting a restorative state to manage chronic pain and mental health conditions.

Sana competes in the neuromodulation and digital therapeutic space for pain and mental health. Direct competitors include other wearable neuromodulation devices (e.g., gammaCore for migraine, Alpha-Stim for anxiety) and a growing field of prescription digital therapeutics. Its key differentiators are its closed-loop biometric feedback, Breakthrough Device status for pain, and strong DoD backing for PTSD.